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Primary goals, information-giving and men's understanding: a qualitative
study of Australian and UK doctors' varied communication about PSA
screening
Abstract

Objectives (1) To characterise variation in general practitioners' (GPs') accounts of communicating with
men about prostate cancer screening using the prostate-specific antigen (PSA) test, (2) to characterise GPs'
reasons for communicating as they do and (3) to explain why and under what conditions GP communication
approaches vary. Study design and setting A grounded theory study. We interviewed 69 GPs consulting in
primary care practices in Australia (n=40) and the UK (n=29). Results GPs explained their communication
practices in relation to their primary goals. In Australia, three different communication goals were reported: to
encourage asymptomatic men to either have a PSA test, or not test, or alternatively, to support men to make
their own decision. As well as having different primary goals, GPs aimed to provide different information
(from comprehensive to strongly filtered) and to support men to develop different kinds of understanding,
from population-level to 'gist' understanding. Taking into account these three dimensions (goals, information,
understanding) and building on Entwistle et al's Consider an Offer framework, we derived four overarching
approaches to communication: Be screened, Do not be screened, Analyse and choose, and As you wish. We
also describe ways in which situational and relational factors influenced GPs' preferred communication
approach. Conclusion GPs' reported approach to communicating about prostate cancer screening varies
according to three dimensions-their primary goal, information provision preference and understanding
sought-and in response to specific practice situations. If GP communication about PSA screening is to
become more standardised in Australia, it is likely that each of these dimensions will require attention in
policy and practice support interventions.
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Abstract
Objectives (1) To characterise variation in general
practitioners’ (GPs’) accounts of communicating with
men about prostate cancer screening using the prostatespecific antigen (PSA) test, (2) to characterise GPs’ reasons
for communicating as they do and (3) to explain why and
under what conditions GP communication approaches
vary.
Study design and setting A grounded theory study. We
interviewed 69 GPs consulting in primary care practices in
Australia (n=40) and the UK (n=29).
Results GPs explained their communication practices in
relation to their primary goals. In Australia, three different
communication goals were reported: to encourage
asymptomatic men to either have a PSA test, or not test, or
alternatively, to support men to make their own decision.
As well as having different primary goals, GPs aimed to
provide different information (from comprehensive to
strongly filtered) and to support men to develop different
kinds of understanding, from population-level to ‘gist’
understanding. Taking into account these three dimensions
(goals, information, understanding) and building on
Entwistle et al’s Consider an Offer framework, we derived
four overarching approaches to communication: Be
screened, Do not be screened, Analyse and choose, and As
you wish. We also describe ways in which situational and
relational factors influenced GPs’ preferred communication
approach.
Conclusion GPs’ reported approach to communicating
about prostate cancer screening varies according to three
dimensions—their primary goal, information provision
preference and understanding sought—and in response
to specific practice situations. If GP communication
about PSA screening is to become more standardised
in Australia, it is likely that each of these dimensions
will require attention in policy and practice support
interventions.

Introduction
Worldwide, many men undergo regular prostate-specific antigen (PSA) screening for
prostate cancer risk in primary care. We will

Strengths and limitations of this study
►► Qualitative

methodology is well-suited to
investigating complex multifaceted processes,
like communicating about prostate-specific
antigen (PSA) screening from the perspective of
clinicians, and preserves important contextual
information relating to the process.
►► Data were from a large, rigorously derived sample
of general practitioners (GPs) from different practice
types and locations, and in two countries. The four
approaches identified in this study may be applicable
to a wide range of practice settings.
►► It is possible that those GPs who did not participate
were in some way different to those who did (ie, that
these data are subject to selection bias); however,
the diversity in our respondents suggests that it is
very unlikely that our sample was biased towards a
particular view of PSA screening or corresponding
communication style.
►► As this is a qualitative study, we cannot infer
prevalence of the four reported approaches;
the results of this study could be extended into
quantitative survey research with whole populations
of GPs to test prevalence.
►► Public and patient perspectives were not included
in this study; additional qualitative research might
explore their experiences of communicating with
clinicians about prostate screening, to further inform
policy and practice.

use PSA screening to refer to PSA testing in
ostensibly healthy men who are not considered to be at high risk of prostate cancer for
their age; this contrasts with PSA testing in
men who have a diagnosis of prostate cancer
or are experiencing acute symptoms that may
suggest prostate disease. Although the value
of the PSA test as a screening tool is scientifically contentious, the public perception
of prostate screening is reportedly positive,
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Figure 1 Chan et al identified a core set of key facts that clinicians should include in an ‘ideal’ discussion about PSA
screening.

including an inflated sense of the benefits and underestimation of the harms.1 Access to a PSA test is often via
general practitioners (GPs). The large number of men
screened in some countries, and the extent of public
misperception and scientific contention, makes the
communication between men and their GPs about prostate cancer screening especially important.
Communicating about screening is difficult. In-depth
discussions about cancer screening can be complex and
may involve multiple statistical concepts, such as test
sensitivity and specificity, and absolute and relative risk
reduction figures from trial-based evidence. Chan et al
identified >20 specific informational items that experts
and patients identified for inclusion in an ‘ideal’ discussion about prostate screening.2 The authors synthesised
the items into a core set of key facts that clinicians should
provide about PSA screening to their patients (figure 1,
developed by KP); however, we note that even some of
these items are contentious or inconsistent with the
various national guidelines that we will discuss in the next
section.
Proposed communication standards for PSA screening
discussions are reportedly challenging to implement
in clinical practice.3–5 PSA tests are often ordered in
the absence of any discussion; in the USA, men report
being unaware of being screened,6 not being asked for
their screening preferences and undergoing PSA testing
without first discussing it with their doctor.7 Clinicians
2

report offering screening without prior counselling.8 A
survey of US physicians reported that 20% acknowledged
ordering PSA without telling patients.9 This can be for
various reasons.10 Volk et al surveyed US physicians and
found that those physicians who reported ordering PSA
tests without discussion were more likely to believe that
patients wanted to be screened and that education is
not needed. This was in contrast to those physicians who
engaged patients in prescreening discussion because they
believed patients should know about the lack of evidence
supporting screening.11 Physician beliefs about the limitations of the scientific evidence for PSA screening, the
questionable utility of the PSA test and ethical concerns
regarding patient autonomy have also been identified as
influencing the likelihood of discussions in US studies.10 12
Physician beliefs can shape the content of discussions;
in a UK study, the strong personal views of clinicians
against the value of PSA screening were reportedly clearly
portrayed in their presentation of information about
prostate cancer screening.13
In addition to this work on physician knowledge, values
and attitudes, some researchers have studied patient and
practice factors that may facilitate or preclude discussions
about prostate cancer screening. For example, in one
study US physicians were less likely to discuss screening
if a patient had already made a decision about screening
or was perceived to have limited ability to understand the
information.10 Other studies have reported on factors
Pickles K, et al. BMJ Open 2017;8:e018009. doi:10.1136/bmjopen-2017-018009
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Table 1 Recommendations of professional organisations in terms of communicating about prostate screening
Items included in
recommendation and
guidance
Is GP advised about whether to
raise the topic with men if men
do not raise it first?
Is a decision aid
recommended?

Professional organisation
PCFA/CCA NHMRC RACGP USANZ NICE NHS/PHE USPSTF ACS

✓

✓

✓

✓

✓

✓

Is a decision aid provided?
Is IDM* recommended?

✓

✓

Is guideline accompanied by a
patient information sheet?§

✓
✓

✓

✓

✓

✓

✓

Does guideline recommend
clinician to share their own PSA
screening decision?
Consider medico-legal
responsibilities?

✓

✓

✓
✓

✓
✓
✓

✓
✓

AUA

✓

✓

Is SDM† recommended?
Is guideline accompanied by a
clinician information sheet?‡

✓

NCI

✓

✓

✓
✓

✓

✓
✓

✓

*The patient is presented with all the information pertinent to making a decision and then assumes final authority for the decision.30
†The patient is provided with all the relevant information and works with the healthcare provider to reach a decision that reflects the health
preference of the patient.30
‡A clinician information sheet is a fact sheet summarising the evidence of benefits, limitations and associated risks of prostate screening to
help clinicians to accurately inform men.
§A patient information sheet is a fact sheet outlining the benefits, limitations and associated risks of having a PSA test for prostate cancer
risk.
ACS, American Cancer Society; AUA, American Urological Association; GP, general practitioner; IDM, informed decision making; NCI,
National Cancer Institute of the National Institutes of Health; NHMRC, National Health and Medical Research Council; NHS/PHE, National
Health Service/Public Health England; NICE, National Institute for Health and Care Excellence; PCFA/CCA, Prostate Cancer Foundation of
Australia/Cancer Council Australia; PSA, prostate-specific antigen; RACGP, Royal Australian College of General Practitioners; SDM, shared
decision making; USANZ, Urological Society of Australia and New Zealand; USPSTF, United States Preventive Services Task Force.

affecting the quality of discussions, including a lack of
time and the complexity of the topic.9
Clinicians have cited clinical guidelines and scientific evidence about prostate cancer screening as factors
guiding their practice.13 However, this professional guidance varies widely, which may partly explain the observed
variation in practice. Table 1 outlines the recommendations of key professional organisations in relation to
communicating about prostate cancer screening, illustrating the main points of difference. ‘Informing’ men
about the benefits and harms of PSA screening is universally recommended; and use of decision support tools is
recommended by half of the professional organisations.
Only 4 of the 10 guidelines advise whether GPs should
raise the topic of PSA screening with men who do not ask
about it in routine consultations. Medico-legal issues are
referred to in only one, Australian, guideline. In practice,
clinical guidelines may not always help GPs to decide how
and what to communicate about PSA screening.14
Entwistle et al characterised the two main ways that
healthcare organisations communicate with the public
about screening—Be screened and Analyse and choose—and
proposed an alternative approach to communicating
Pickles K, et al. BMJ Open 2017;8:e018009. doi:10.1136/bmjopen-2017-018009

about screening, which they termed Consider an offer.15 The
Consider an offer approach suggests healthcare providers
should support people to assess an offer for screening,
with a recognition that people may reasonably decline
such offers. Consider an offer guides clinicians and patients
to consider the source of screening recommendations
and professional guidance. We return to the Consider an
offer approach in the ‘Discussion’ section.
This study draws on a larger body of work investigating clinicians’ approaches to, and reasoning about,
PSA screening in Australian and UK general practice.
Despite similar levels of prostate cancer mortality, both
PSA screening and prostate cancer incidence are lower in
the UK than in Australia.16–19 Previous analyses from this
study have illuminated systemic variation between the two
jurisdictions, including in payment models, the history
of PSA screening policy, screening culture and referral
patterns.14 The authors have also published earlier findings from the empirical work about how clinicians manage
the potential for overdiagnosis20 and their responses to
uncertainty in relation to prostate screening.21 Table 2
summarises our previous findings regarding differences
in PSA screening in the two jurisdictions. Note that
3
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Table 2 Organisation and occurrence of prostate-specific antigen (PSA) screening in Australia and the UK
Australia

UK

For men asking about ►►PSA screening is available. GPs are advised to ►►PSA screening is available, but with conditions.
prostate screening
offer evidence-based decisional support to men
The National Health Service Prostate
considering whether or not to have a PSA test,
Cancer Risk Management Programme has
including the opportunity to discuss the benefits
recommended that screening for prostate
and harms of PSA screening before making the
cancer be available for asymptomatic men, on
decision.
the understanding that they have been provided
with full and balanced information about the
advantages and limitations of the PSA test.
Screening frequency ►►GPs reported frequently providing PSA
►►GPs reported that PSA screening was rare in
screening within routine consultations.
practice.
►►GPs reported often initiating discussion of PSA ►►UK GPs reported not promoting PSA screening;
screening; GPs reported commonly receiving
they also reported that men rarely asked for
requests for PSA screening.
PSA screening.
Guidance for GPs

►►GPs are free to practice according to individual

Preferred form of
information provision

►►GPs reported generally informing men via a

►►Government-issued standards for PSA
standards.
screening and communication processes in
clinical settings are in place.
►►Australian guidance was mixed (see table 1). The
National Health and Medical Research Council ►►Guidance has been distributed to all GPs in
has recently issued guidance to Australian GPs
England and Wales to assist in the provision of
to drive greater consistency in practice.
information to men.
►►GPs can choose to follow issued guidance but
seem inclined to operate within the bounds of
their health system.
►►GPs reported relying on a standardised printed

verbal discussion of PSA screening.

information leaflet. This was central to the
consultation, sometimes alongside a brief verbal
discussion.
Appointment structure ►►PSA screening tests were usually discussed and ►►Information-giving occurred in a separate
ordered in a single appointment.
appointment to PSA screening itself.
Summary of findings and details reported in Pickles et al 2016.
GP, general practitioner.

prostate cancer screening is not recommended in either
location.
In the light of our prior findings on variation between
the Australian and UK contexts, we set out to better
understand GP communication practices in particular.
The larger programme of study examined the role of
values, ethics, context and evidence in cancer screening
policy and practice. In this paper, we present an analysis of how GPs in Australia and the UK explain their
approach to communication with men about prostate
cancer screening. We asked the following research questions in respect of both settings:
1. How do GPs describe their communication with men
about prostate cancer screening?
2. What are the reasons given by GPs for communicating
with men as they do?
3. Why and under what conditions do GPs
communication approaches vary?
Methods
GPs had an opportunity to discuss the study with KP
prior to participation; all GPs provided informed written
4

consent to participate and were compensated $A100 for
their time. Participation was voluntary, participants could
withdraw at any time and confidentiality was protected.
All responses were anonymised before analysis and potentially identifying information removed.
Design
We applied the well-established, systematic qualitative
research methodology of grounded theory.22 Grounded
theory is a method of conducting qualitative research
that focuses on creating conceptual frameworks or theories through building inductive analysis from the data.
All study authors have been formally trained in qualitative research methods; SC has particular expertise in
grounded theory methodology.
Participants and setting
We identified clinicians working in primary care practices as being in the best position to provide insight on
our research questions, and most likely to face the question of PSA screening as part of their everyday practice.
We purposively recruited a sample of GPs first in the
Australian healthcare setting, and later in the UK
Pickles K, et al. BMJ Open 2017;8:e018009. doi:10.1136/bmjopen-2017-018009
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(England, Scotland and Wales), as our study evolved.
Sampling for the broader study was initially driven by
existing quantitative evidence on characteristics of GPs,
patients and practice contexts associated with higher or
lower PSA screening rates. We aimed to recruit a set of
GPs likely to have diverse practices. See Pickles et al14 for a
detailed description of the recruitment process.
In Australia, we advertised in newsletters and email lists
of GP organisations, in mass and social media, medical
journals, we phoned practice managers and via email and
flyers distributed by rural GP organisations. In the UK,
academic colleagues distributed an invitation through
their professional networks, we advertised to members
of the Royal College of General Practitioners (RCGP),
primary healthcare departments, university academic
departments, and general practice and research via
mail lists, and in organisational newsletters including
the Society for Academic Primary Care and RCGP
Scotland’s eBulletin. GPs were invited to contact KP if
they were interested and willing to participate. An information sheet outlining the research project was emailed
to all respondents. All GPs who expressed interest in
participating were included.
Overall, 69 GPs participated in this study, 40 GPs in
Australia and 29 GPs in the UK. 44/69 of the GPs were
male. The GPs ranged in clinical experience, working
from 1 to 40 years in general practice, and were located
in both metropolitan (n=32/69) and regional/rural
(n=37/69) clinics, with varied patient populations.
Data collection
The field work for the prostate cancer element of this
study was conducted by KP, a public health researcher,
as part of a PhD degree. KP had no immediate personal
or professional experience with prostate cancer or PSA
screening.
We generated data via in-depth semistructured interviews. An interview guide was prepared to provide general
direction and an overview of potential question routes.
The interview guide covered a broad range of topics,
including GPs’ recent clinical encounters involving PSA
screening decisions, communicating information about
the PSA test to patients; screening pathways and overdiagnosis of prostate cancer. Example questions asked about
communication included
►► Describe a recent consultation with an asymptomatic
man involving the PSA test … Can you take me right
back to the beginning and tell me as much as you can
about the consultation. Who initiated the conversation about the PSA test?
►► Should men be informed about overdiagnosis, false
positives before having a PSA test?
►► How well do you think men understand PSA screening?
The schedule was reviewed and modified between
interviews based on the developing analysis to enrich
the data available to answer our research questions.
All GPs were asked to think back to their most recent
consultation involving a discussion about PSA screening
Pickles K, et al. BMJ Open 2017;8:e018009. doi:10.1136/bmjopen-2017-018009

or to describe a typical consultation where the topic was
raised.
Interviews took place between March 2013 and June
2014 (Australian GPs) and between September and
December 2014 (UK GPs). We continued to interview GPs
until we judged we had reached theoretical saturation;
that is, the point at which gathering more data ceases to
yield any further insights about the emerging grounded
theory. All interviews were conducted by KP, primarily
by telephone or Skype, and ranged in duration from
18 to 70 min. With GP permission, the interviews were
audio-recorded and transcribed verbatim by a professional transcribing service to produce data for analysis. Transcripts were not returned to participants for
comment; all participants will receive a written summary
of the research findings on study completion.
Data coding and analysis
The analysis was led by KP, who coded the transcripts. A
subset of transcripts was read and coded by three authors
independently to ensure interpretive rigour. We coded to
capture the range of variation in the GP-reported discussions about PSA screening and for conditions that could
explain that variation. Codes were kept as similar to the
data as possible to preserve context and to ensure that
all concepts derived directly from the data. Codes were
compared and discussed to inform the development of the
central concepts in the study. KP wrote detailed memos
during data collection and analysis which were reviewed
and discussed by the authors in analysis meetings.

Results
We observed considerable diversity in the ways that GPs
described their communication about prostate cancer
screening. Although the majority of variation occurred
among Australian GPs, we also report on data from the UK
because this helps illuminate the contrasting complexity
of the Australian data, including the role of local context.
We first explain how Australian GPs varied in their
descriptions of their communication. We then consider
important ways in which UK and Australian GPs were
similar and different.
Australian GPs’ accounts of communicating with men about
prostate cancer screening
Australian GPs’ accounts varied greatly in how they introduced conversations about PSA screening with men, how
screening discussions were framed and their perceived
informational obligations.
Screening men with little or no prior communication
A minority of interviewees reported ordering PSA tests
for asymptomatic men with little or no prior communication with the patient. GPs were categorised as
non-communicative if they reported (1) ordering
PSA tests without explaining that to their patient, (2)
ordering PSA tests at patient request with no further
5
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discussion or (3) explaining PSA screening only after
a positive PSA test result. We encountered occasional
practices from which asymptomatic men were mailed
pathology forms for a PSA test via practice recall
systems, bypassing a GP consultation and opportunity
for discussion.
Several possible justifications were provided by
non-communicative GPs:
►► Some GPs reasoned that because the information
about PSA screening was ‘confusing’ ‘complicated’
and potentially contradictory, it should not be
provided.
►► Some GPs said their role was to ensure that men could
be screened if they wanted, ‘I see doctors purely as
enablers, of what people want … If you don't want to
read about it [the test], then fine; I’ll just order one
for you’ (AGP17).
►► Some GPs considered it ‘up to each patient to be
informed appropriately’ (AGP14); if a man requested
a PSA they would order a test assuming that man felt
sufficiently informed from other sources.
►► Some GPs considered it unnecessary to provide information unless the man received a cancer diagnosis,
‘I don’t think they need all that information at the
level of PSA testing. I think, that once you’ve got your
cancer diagnosis, you can talk about what you want to
do with that then’ (AGP26).
►► Some GPs did not appear to have a complete understanding of the epidemiological data, for example,
‘someone was saying that a certain number of people
had to have radiation and surgery and have impotence and incontinence, for one person’s life to
be saved. I mean—I don’t know how you get those
figures’ (AGP2).
These were, however, minority views. We focus in what
follows on the majority of GPs who did communicate with
men in some way about PSA screening.
Communicating with men, with variation on three key
dimensions
We identified three dimensions central to GP discussions
with men about PSA screening:
1. The GPs’ primary communication goal. Some GPs
had the goal of convincing the patient to screen, some
had the goal of convincing the patient not to screen,
and some had the goal of supporting decisions or facilitating patient choice.
2. The type of information the GP provided.
3. The type of patient understanding the GP sought to
achieve.
It appeared that dimension 1 was dominant; GPs
communicated in accordance with their preferred goal
or outcome of the communication. In most cases, the
GP’s positioning on dimensions 2 and 3 was grounded
in whether the GP felt strongly that patients should be
screened or not, and the degree to which they directed
men towards that preference. Below we explain these
three dimensions and GPs’ reasoning about them.
6

Dimension 1: GPs’ primary communication goal
Some GPs aimed to convince men either to agree to be
screened or to agree not to be screened. These GPs had
strong beliefs regarding whether or not PSA screening
should occur routinely, and wanted patients to follow
their advice, their ‘guide … down the path’ towards what
they ‘thought was best’ (AGP29). GPs acknowledged ‘bias
will creep into that’ (AGP29); ‘you can’t help yourself but
… what you believe in is the way you push the consultation’ (AGP18). However, this approach was justified by
beliefs that ‘… you can only do what you think is best
for the patient’ (AGP29) and ‘a lot of people do want to
be told what to do … doctors are their reference point’
(AGP31). GPs recognised that men sometimes chose not
to take the advised pathway, for example, ‘there are times
when it wouldn’t matter what you said to a patient they’re
still determined to have the test’ (AGP18).
An alternative communication goal was to support men
to make decisions about screening consistent with their
own values and preferences. GPs with this goal aimed to
facilitate an informed decision-making process and were
determined to provide information to all men ‘to make
up their own mind’ (AGP16), because ‘with the PSA test,
I can’t so easily say to myself, well, it’s in your best interests
so I don’t need to inform you properly’ (UKGP9). GPs
with this goal reasoned that a man ‘should be empowered
to know everything’ (UKGP28); ‘should have the right
and want to be able to make that decision for themselves
about whether they have the test or not’ (AGP5).
Dimension 2: GPs’ reported information provision
Because GPs had different goals in communicating,
they provided different information, in both quality and
quantity.
Some GPs claimed to provide men with ‘complete’ and
‘unbiased’ information because they considered it their
‘ethical obligation’ as a health professional to do so; the
patient, in this view, had a ‘right’ to be fully informed,
so GPs should ‘[put] all the information on the table’
(AGP31); ‘I’m very keen that people are well-informed
about really what it means if they are to undertake a PSA
rather than just simply agreeing to what their idea might
be’ (UKGP23). This sometimes extended to teaching
patients how to locate and interpret information for themselves. Informing patients was described by some GPs as
serving a self-protective legal purpose, ‘I’ve informed the
patient, the patient made his own decision, so he’s got to
then accept the consequences’ (AGP19).
In contrast to GPs who sought to provide comprehensive information, other GPs filtered information to ‘actually tell them [patients] what counts the most’ (AGP4).
Here GPs aimed to explain their own best judgement
about the evidence, framing the evidence according to
the GP’s opinion regarding the value of PSA screening.
This often took the shape of a personal recommendation
either to have a PSA test or not. One GP, for example,
said ‘[patients] don’t have that knowledge so you sort of,
give an explanation why it needs to be done’ (AGP35);
Pickles K, et al. BMJ Open 2017;8:e018009. doi:10.1136/bmjopen-2017-018009
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another, in contrast, thought ‘my discussing it has probably been biased towards not getting it done’ (AGP16).
Some GPs considered such advising to be best practice
because information provision alone was not enough to
help men decide what to do. For example, one GP who
favoured PSA screening reasoned, ‘If they really don’t
know what to do then [after receiving information], any
doctor would be a fool not to say look, get it investigated
because, the most stupid thing anyone could do is say
oh don’t bother about it … that’s just a total recipe for
disaster’ (AGP31).
Dimension 3: GPs’ reported ambitions for men’s understanding
All GPs aimed to support the development of patient
understanding. However, there were two different conceptions of what constituted appropriate understanding of
the information presented and available options:
1. Sometimes GPs aimed to assist men to develop detailed population-level understanding of the evidence.
They wanted men to understand all aspects of the
information provided and described checking understanding, identifying gaps in patient knowledge,
and clarifying misunderstandings, because ‘I don’t
think their pre-existing understanding of the test is
very good at all in most cases’ (UKGP21). Some of
these GPs reported feeling personally and professionally responsible for presenting the ‘right amount’ and
‘right level’ of information for individual patients,
‘[achieving understanding is] really the doctor’s job,
and our skill in trying to explain all that complicated evidence, as best as we can’ (AGP19). Some GPs
commented they hoped men understood the detail of
the evidence, otherwise it indicated they as a GP had
done a ‘bad job of explaining it’ (AGP6); however,
they also explained ‘it’s a very difficult thing to formally confirm that they understand the implications
of having the test done without kind of interrogating
them’ (UKGP1).
2. Alternatively, GPs might aim for men to develop overall ‘gist’ understanding. GPs committed to ‘gist’ understanding were satisfied if their patient had a less
complete grasp of the intricacies of the evidence base
as long as they had an overall understanding of what
the GP perceived to be core issues; ‘I feel like as long
as they can understand that basic concept [in this instance, that PSA is not a perfect test] … then I feel like
it’s okay to still do the testing, even if they don’t understand all the detail … I feel like that’s a reasonable
level of understanding, I don’t feel like people need to
have an absolutely thorough kind of understanding’
(AGP5). Those GPs who thought ‘gist’ understanding
was acceptable thought it was reasonable for men to
trust their doctor to advise them appropriately.
Relationship between the dimensions
When taking account of the three dimensions along which
GPs varied, we identified four overarching approaches
to communication: (1 and 2) Be screened and Do not be
Pickles K, et al. BMJ Open 2017;8:e018009. doi:10.1136/bmjopen-2017-018009

screened (GPs who guided men towards screening or not
screening); (3) Analyse and choose (GPs who aimed to
ensure men made their own independent, informed decision, based on a detailed population-level understanding);
and (4) As you wish (GPs who simply facilitated the man’s
stated preference to be screened or not screened). Two
of these terms (Be screened and Analyse and choose) align
with Entwistle et al’s characterisation of communication
approaches,15 as outlined in the introduction. Each GP
we interviewed had a general preference to employ one
of these four approaches in their everyday communication about PSA screening. In table 3, we present an integrated illustration of the characteristics of each approach,
ordered according to the three key dimensions evident in
the GP accounts.
Be screened or Do not be screened interactions
If GPs had a strong preference that men should either
be screened or avoid screening, they communicated in
a directive way, oriented to encouraging the man either
to screen or avoid screening respectively. This included
offering personal judgement about the value—or
harms—of PSA screening or framing the information
they provided towards or away from screening. Some GPs
gave a recommendation without offering men any further
information. In Be screened and Do not be screened interactions, GPs considered it sufficient that men developed gist
understanding of the information provided because they
thought it was reasonable for men to trust their doctor to
advise them appropriately. These GPs strongly believed
either that men should be screened routinely, or that they
should not be screened at all, and they wanted patients to
follow their advice.
Analyse and choose interactions
If GPs aimed to support men to make their own decisions,
consistent with the man’s personal preferences (ie, a
patient-directed decision), then they were not directive in
their communication. In these interactions, GPs aimed to
provide a comprehensive and impartial summary of the
best available evidence; their goal was to ensure that men
developed a detailed population-level understanding of
their options in order to make an informed decision.
They saw this as a neutral, educative role. For some, this
approach was protective against potential medico-legal
threats. GPs using this approach may personally favour
either screening or not screening, but their primary
commitment was to support the man’s decision, regardless of their own professional beliefs about screening.
As you wish interactions
Sometimes GPs acted on patient wishes to be screened or
not screened without questioning. In these interactions,
GPs did not attempt to direct men in any particular direction, and often provided little information, ensuring that
the man understood PSA screening was not a priority. In
some cases, GPs perceived men to have already made a
screening choice based on personal preference or gist
7
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Table 3 Four general practitioner (GP) approaches to communication about prostate-specific antigen (PSA) screening in
clinical interactions
Be screened interactions
GP’s primary goal:
►►GP strongly believed that the man should be screened
►►GP’s goal is to convince the man to screen
Information provided by GP:
►►GP’s personal judgement about the value of PSA screening
►►GP either tailored information provided to men to encourage
men to be screened or did not provide information (provided
only encouragement to be tested)

Do not be screened interactions
GP’s primary goal:
►►GP strongly believed that the man should not be screened
►►GP’s goal is to convince the man not to screen
Information provided by GP:
►►GP’s personal judgement about the harms/downsides of
PSA screening
►►GP either tailored information provided to men to
discourage screening or did not provide information
(provided only encouragement to avoid testing)

Type of understanding that GP considered adequate:
►►Gist understanding of information provided

Type of understanding that GP considered adequate:
►►Gist understanding of information provided

Analyse and choose interactions
GP’s primary goal:
►►GP may personally support testing or not testing
►►Despite their personal beliefs about testing, GP’s goal is to
help the man to make his own informed decision

As you wish interactions
GP’s primary goal:
►►GP may or may not have a strong position on the value of
PSA screening
►►GP’s goal is simply to follow the man’s expressed
preference

Information provided by GP:
►►GP aimed to provide a comprehensive and impartial
summary of best available evidence
Type of understanding that GP considered adequate:
►►GP’s goal was to ensure men developed detailed
understanding of their options, to make own informed
decision

Information provided by GP:
►►GP provided little information

understanding. These consultations typically involved
men with an already-established screening preference,
mostly for screening; the GP simply acted in line with the
man’s instructions.
How GPs negotiate communicating within specific contexts
Many Australian GPs reported discussing PSA screening
with men often, so had a prepared basic ‘spiel’; as one
reported, ‘the PSA is such a common question that you
get asked and you just have to have some idea in your
head what you’re going to say when they come in’
(AGP18). This spiel could be tailored to specific contexts
as necessary. GPs’ interviews indicated that they tended
to have a preferred approach for most PSA interactions
(to guide patient towards screening or not screening,
to support men to make their own decision or to act in
accordance with the man’s expressed preference) or that
they had maintained a particular communication style
over time. However, we identified 11 situational and relational factors (see table 4) that GPs described as temporarily shifting their usual or preferred communication
goals and processes. These factors predominantly arose
from specific circumstances of individual consultations.
GPs described modifying their provision of information
and/or advice, depending on the 11 factors described in
table 4.
8

Type of understanding that GP considered adequate:
►►Ensuring men understood was not a priority for the GP;
in some cases, GP perceived men to have already made
a screening choice based on personal preference or gist
understanding

GPs also shifted between the four communication
approaches more readily when they were presented with
complex cases; producing more fluid, responsive and
sometimes ‘quite inconsistent’ (AGP16) conversations.
Many GPs did have a primary goal when communicating
(to encourage or discourage screening, or to support the
man to make his own decisions) but these could change
in different situations. Also, some men did not take
the advised pathway—either towards screening or not
screening, or some men preferred the GP to direct the
decision, not wanting to engage with information or to
make their own decision.
Comparison of communication approaches in Australia and
the UK
UK GPs generally did not communicate about PSA
screening unless men asked about it, so they often
neither communicated about it as a screening test, nor
ordered it. When men asked for a PSA test, information
provision was central to consultations in the UK context,
and most UK GPs commonly practised according to the
Analyse and choose or Do not be screened approaches. Few UK
GPs described adjusting their conversations about PSA
screening with patients.
The reported consistency of PSA communication
practices in the UK contrasted strongly with the significant
Pickles K, et al. BMJ Open 2017;8:e018009. doi:10.1136/bmjopen-2017-018009

Examples of how GPs reported modifying their communication
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►►Conversations with men with family history of prostate cancer were described as being slightly different; some GPs said their interactions with
these men would be more ‘considered’ and ‘gentle’ despite the majority of the men knowing their decision before coming to the doctor.
►►Some GPs who generally communicated in a way to achieve screening (Be screened) or not screening (Do not be screened) changed their
approach more towards Analyse and choose and As you wish in situations where a family history was implicated—for both those determined to
be tested and those not wishing to be tested.
►►These patients were perceived to have positive preconceptions about PSA screening which pre-empt any GP discussion.
►►Some GPs who would usually communicate with a particular goal in mind (Be screened or Do not be screened) said any conversation counter
to the man’s beliefs was not a productive conversation because their intentions could not be changed; ‘they see it as their right to have it [a PSA
test]’ (AGP15); ‘he was so definite he wanted it’ (AGP6). GPs tended to take the As you wish approach in these situations, even if this was not
their preference.
►►‘I think that what changes in that situation is their determination to have the testing done, most of these men have made a decision before I’ve
said anything, that they’re going to be tested, no matter what I say’ (AGP8).
►►Some GPs reasoned that a man’s interest in PSA screening would drive the discussion, ‘it tends to be very patient specific and tailored advice …
and depends on what I think that they expect and hope to hear and are likely to do’ (AGP16).
►►GPs who usually took an As you wish approach, so did not communicate, would in some situations be required to shift to one of the other three
approaches (Be screened, Do not be screened, Analyse and choose) because the man requested information.
►►Some GPs said the discussion would become ‘more complicated’ the more interested the patient was.

Patient had a family history of prostate
cancer

Patient requested to receive a PSA test or
was perceived to be determined to have
a test

Patient was interested in finding out more
about screening

►►Some GPs who preferred an Analyse and choose approach engaged in less detailed discussion with patients about PSA screening when they
were short of time. They described selecting out the information to include in discussions with men when they were time poor, more in line with
the Be screened or Do not be screened approaches.
►►Some GPs said it is often simply impractical to provide full information and support patients to develop detailed population-level understanding
at each appointment so on occasions they ‘just haven’t had time to give a full spiel so I order it and I will have the discussion later with them, if
it’s positive’ (AGP13).

Time available for the consultation (GP
short of time)

Continued

►►Some GPs were influenced by their access to a urologist. Although they might prefer to recommend that men Be screened or Do not be
screened, they described instead shifting their approach towards Analyse and choose when based in a rural location; I ‘just might try to explain
the test, do a bit more pre-test counselling with the patient when I was in the country, just because I knew that I’d then be managing the result
rather than just sending them onto a Urologist, like it’s easy to do in Sydney’ (AGP5). GPs described how in rural locations it is common for GPs
to have to manage abnormal PSAs for a longer period before they can access urologists for a second opinion. Some GPs were uncomfortable
with this situation and consequently aimed to involve men more in the decision from the beginning.
►►Some GPs would talk to patients after PSA screening if it was abnormal but not before; that is, they would take either a Be screened or As you
wish approach before testing, and provide counselling if needed after testing. These GPs perceived some men as resistant to seeing a GP
at all, so thought it important to be seen to do a test because it was ‘something’ proactive for them while they were there, rather than simply
talking.

Rural location with limited access to
urology services

Situational factors … pertaining to service characteristics

►►Some GPs paid closer attention to which direction they ‘coaxed’ patients in these age groups; for example, some would particularly emphasise
false positives and the potentially harmful diagnostic pathway to younger men under 50 years (ie, GP more likely to use Do not be screened
approach).
►►Some GPs who usually communicated in Be screened mode provided comparatively less detailed information for older patients, particularly
those with declining memory or those they perceived as being cognitively unable to ‘handle the information’, and ‘pick[ing] the details of the
intricacies … and a lot briefer [conversation]’ (AGP17).
►►Some GPs described defaulting to providing stronger recommendations with elderly men.

Patient was from an older or younger age
group (particularly <50 years or >75 years),
or had comorbidities

Situational factors … pertaining to patient and/or GP

Situations that encouraged particular
approaches to communication about
PSA screening, as described by GPs

Table 4 Effect of situational and relational factors on general practitioners’ (GPs’) approaches to communication in prostate-specific antigen (PSA) screening interactions,
as described by GPs
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Examples of how GPs reported modifying their communication

►►Sometimes GPs provided minimal information to manage anticipated patient anxiety; ‘if you put too much information out there…most of it
doesn’t go in … there’s too much information … it’s not possible for people to take that stuff in, they don’t even want to’ (AGP7).
►►In such cases, GPs who would usually communicate in Analyse and let choose mode, acted in what they saw as their patient’s ‘best interests’
(towards Be screened or Do not be screened), which could involve no communication, or being selective with the information they shared.

Patient was perceived to be anxious, and
so not receptive to information

Patient was the usual patient of another
GP, and patient asked for a PSA test

►►Sometimes GPs who preferred an Analyse and choose approach were consulted by patients who were routinely tested by another GP. In this
situation, the GP would assume that the man had heard the talk before. They responded to this situation in several ways:
►►Some GPs shifted to either the Be screened or As you wish approach and ordered PSA tests without discussing it with the man, reasoning that
the discussion could be revisited if the PSA was abnormal.
►►Some GPs maintained Analyse and let choose mode and actively engaged patients in a discussion because they did not know what men had
heard from previous GPs. This was sometimes with a view to changing the patient’s mind: for example, ‘I am trying to create permission and faith
for me to open the discussion up again, rather than just keep redoing the test’ (AGP30).
►►Some GPs found this position incredibly challenging if they preferred not to test (ie, Do not be screened); ‘because you have to undo the
patient’s expectations … you’ve got to decide whether you just go with the flow … or you sit down and ascertain what their appetite for
negotiating is. Some of them are just locked into it and it’s too late’ (AGP23).

Relational factors … pertaining to service characteristics

GP aware of patient history of screening
►►Some GPs who would prefer the Analyse and choose approach said they ‘may not give a full spiel’ (AGP13) to men who have been screened
(GP has screened patient in the past or
before and ‘often do it [discuss] a little more quickly, because it is clear that they remember it from the year before. And if they are men
has discussed screening with patient
who made the decision last year to have the test done, then they are often going to make the same decision this year … so it’s a quicker
previously, GP knows patient’s screening
conversation, but it’s not a non-conversation. And it depends on the patient and how well I know them’ (AGP30). In these situations, GPs tended
preferences, or GP knows patient has been
to shift to an interaction more like one of the other three approaches.
screened previously)
►►Some GPs were more likely to initiate screening with men who had had PSA screening with them in the past or had had many PSA tests,
because ‘generally a lot of my patients by now have had the spiel so many times that they often will, come in and say “It’s time for my yearly
prostate test’ (AGP29).

GP made a judgement that the patient was ►►GPs were often more inclined to take the option of As you wish in situations involving well-informed men, regardless of the GP’s usual practice.
‘very switched on’ and had ‘done their
►►Alternatively, GPs might take an Analyse and choose approach and tailor content accordingly; ‘it really depends on the population you’re dealing
homework’
with … what you perceive they are capable of understanding’ (AGP31); ‘You’ve got to target it at the level of the patient basically’ (AGP4).

►►Some GPs who usually favoured Analyse and choose, reverted to a Be screened or Do not be screened approach when communicating was
difficult, ‘If I had a patient who is extremely unintelligent and I tried to explain it and I didn’t seem to be getting through to him, and I felt it was in
his best interests, I might go ahead and do the test [or not do the test] anyway’ (AGP29).
►►Some GPs tailored the content accordingly; ‘it really depends on the population you’re dealing with … what you perceive they are capable of
understanding’ (AGP31); ‘You’ve got to target it at the level of the patient basically’ (AGP4).
►►‘If a man thinks PSA is just a blood test, then I mentally go oh dear, we need to go through this in more detail’ (AGP4).

GP made a judgement that the patient
‘starting point’ in terms of grasping the
information was low and it would be
difficult for them to understand PSA
screening

Relational factors … pertaining to patient and/or GP

Situations that encouraged particular
approaches to communication about
PSA screening, as described by GPs

Table 4
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variation reported in the Australian context (tables 3
and 4). The contextual factors considered in table 4
were uncommon in UK GPs’ accounts due to fewer men
requesting and fewer GPs suggesting prostate screening.
UK GPs mostly reported giving the same standard information leaflet to all men who expressed interest in PSA
screening, regardless of their personal circumstances.
Many GPs practising in Australia tended to filter information, and commonly practised according to the Be screened
approach, but no UK GPs reported using this approach.
We identified different versions of the Do not be screened
approach adopted by Australian and UK GPs. For the
Australian GPs, this approach took the form of a personal
recommendation against screening, directed by the GP
and according to their personal—negative—perspective of PSA screening. For UK GPs, the Do not be screened
approach also involved the GP recommending that the
man should not be screened. However, UK GPs explained
this as enactment of a collective standard of care recommended and issued by the UK National Health Service
irrespective of their own personal preferences for or
against screening.
Discussion
This analysis suggests that GPs’ primary communication
goals are a central component of consultations about prostate screening. Four distinct communication approaches—Be screened, Do not be screened, Analyse and choose, and As
you wish—were identifiable from GPs’ accounts of their
preferred practice.
The terms Be screened and Analyse and choose align with
Entwistle et al’s Consider an Offer framework. We identified two additional ways of communicating unique to our
empirical data, which we labelled Do not be screened and
As you wish. The need for inclusion of a Do not be screened
element is likely a product of the Australian context
where the PSA test is available and widely promoted for
screening purposes in the media, despite the majority of
relevant public health and health professional groups
recommending against routine screening of asymptomatic men. This meant Australian GPs were regularly
consulted by men expecting to be screened, and some
reported feeling obligated to actively direct men away
from wanting a PSA test for that purpose.
The As you wish category is also likely to be, in part,
a reflection of the somewhat market-driven Australian
healthcare system. As you wish interactions occurred when
GPs’ believed men had already made up their minds
about their preferred choice and could not be swayed by
information presented by the GP. This led GPs to implement the man’s choice and order the test despite the lack
of an evidence base to support that decision. There was no
evidence of As you wish interactions in the UK data. As we
previously reported,14 in the UK there is strong guidance
to GPs to practice in a particular way. GPs are expected
to steward limited National Health Service resources, and
the PSA test is not publicly promoted to the same extent,
Pickles K, et al. BMJ Open 2017;8:e018009. doi:10.1136/bmjopen-2017-018009

limiting consumer expectations for screening. All of these
are conceivable explanations for why As you wish interactions were less commonly reported in UK interviews.
The main issues raised by this analysis
The four variants raise important questions about
patient-centred care, consumer demand and the role
of the health professional. It is well established in the
literature that both patients and clinicians are rarely
entirely rational, and may not necessarily know what
is in the patient’s best interest, particularly when
faced with scientific uncertainty.23 24 Humans tend, for
example, to become sensitised to worst-case scenarios
and disregard objective risk probabilities; this makes us
vulnerable to pursuing, recommending or accepting
potentially harmful treatments.25 If this is so, an As you
wish approach could mean patients are more exposed to
increased harms, and that leaving patients to make decisions about their healthcare needs without professional
guidance is potentially maleficent, or at least negligent.
This problem is further complicated by the wide availability of possibly misleading information, provided by
sources that have an interest in inflating perceptions
of cancer risk. Some authors highlight that increased
patient involvement in decision making has potential
for negative social consequences such as increasing
patient demand for unproven services.26 Cribb and
Entwistle reasonably argue that in some circumstances
it may be ethically legitimate for health professionals to
question and even influence the preferences of patients
for these reasons.27
Most current recommendations encourage GPs
to discuss the benefits and harms of prostate cancer
screening with patients. However, there may be considerable variation in what patients want and expect from GPs
prior to making a decision about PSA screening. Degeling
et al ran three community juries on the topic of how GPs
should communicate about PSA screening. Juries heard
extensive expert evidence about PSA screening, consent
and general practice. Two juries of general citizens
(ie, mixed gender and age) concluded that GPs should
ensure men have enough knowledge to make their own
decision. One jury of only men of PSA screening age
concluded that men should be able to trust their GP
(or a specialist) to provide just enough information at
just the right time, expressed concern about the potential for information overload, and thought the degree
of patient involvement depended on the patient.28
This suggests that citizens who are (atypically) well-informed about the benefits and harms of prostate cancer
screening may take different views and have different
expectations on how GPs should communicate about
PSA screening. If this is the case, it may be appropriate for GPs to have at least a range of communication strategies available, to suit the needs of different
patients. Men eligible for, or already receiving, PSA
screening may well prefer for GPs to direct the decision
(Be screened or Do not be screened approaches) to avoid
11

Downloaded from http://bmjopen.bmj.com/ on April 11, 2018 - Published by group.bmj.com

Open Access
uncertainty. However, men’s preferences are arguably
an insufficient guide; other considerations, including
clinical practice guidelines, medical law and clinical
ethics requirements, are relevant to determining what
GPs should do.
A large component of this analysis is about awareness of and sensitivity to context and the importance
of interpersonal relations and their influence on
communication practice (see table 4). Some of the
GPs’ communication decisions, based on situational
or individual factors, were easily justified because the
situation presented was either clinically relevant (eg,
family history, older age) or professionally justified
(eg, low literate patient, patient request). While most
guidelines advising on PSA screening suggest informed
or shared decision making, they do not consider what
may be a ‘best’ approach to situations involving the
many local factors that GPs’ face in day-to-day practice,
including relational factors, implicated in screening
decisions (and the complexities of general practice).
We identified a subtle web of relational issues that
influenced GPs to move between communication
options and particular types of decision pathways.
These included managing colleague associations (what
are GPs to do about patients who have come from a
pro-screening GP to a GP who does not support PSA
screening?), managing business, including patient
lists (patient request, time pressures) and maintaining
patient trust. These issues made the decision-making
process particularly complicated, and in addition to
vague guidance on such matters, perhaps account for
why many GPs appeared to have multiple, dynamic
approaches. Accounting for relational variables as
identified in this study can facilitate nuanced assessment of the different types of support clinicians might
offer people who may struggle with particular decisions29 and allows scope for professional expertise: the
‘art’ of medicine.
Implications for policy and practice
There are variable approaches to communication about
PSA screening, some of which may be considered better
than others. Guidance about communication—not just
about the PSA test itself, but also about how best to
facilitate the decision—may be useful; we suggest there
is a need for further higher-level professional discussions about what the primary goals of GPs should be
when communicating about PSA screening. Coming to
an explicit agreement on what that purpose should be
may assist in improving communication and providing
clearer guidance for GPs working in the Australian
context. For instance, one endpoint (that could be evaluated) may be that men can demonstrate they have a
sense of their values in relation to the available options,
to show evidence of rational, thoughtful and informed
decision making.
12

Limitations
As this is a qualitative study, we cannot infer the prevalence of the reported approaches to communication;
the results of this study could be extended into quantitative survey research with whole populations of GPs to
test prevalence. It is also possible that those GPs who did
not participate were in some way different to those who
did (ie, that these data are subject to selection bias);
however, the diversity in our respondents suggests that
it is very unlikely that our sample was biased towards
a particular view of PSA screening or corresponding
communication style.

Conclusion
This empirical study produced evidence documenting
varied approaches to communication. The reported
consistency of PSA communication practices in the UK
contrasted strongly with the significant variation reported
in the Australian context. In the Australian setting, some
flexibility in communication seems justified. Further,
because of (1) the large number of men implicated,
(2) the known harms of the screening process and (3)
that PSA is not a routine screening programme, we
argue that PSA screening is a particularly pressing case
to necessitate dedicated effort to facilitate conversations that include but go beyond potential harms and
benefits with men. This would include encouraging and
enabling men who ask for screening to look carefully
at why PSA screening is not recommended (to increase
awareness of why a Do not be screened approach is justified). Assisting GPs to facilitate these conversations with
patients should offer the advantage of supporting men’s
autonomy and reducing harm.
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